抗体研发科学家 50-100万

Responsibilities:

Leading a group of scientist and be responsible for the humanization and optimization of antibody candidates generated by hybridoma- or phage display-technology. 
Managing the group and taking responsibility for its projects by driving and coordinating his/her direct reports in achieving the specific objectives of the respective research projects. 
Representing the Biologics department in specific antibody project teams. 
Taking responsibility for defining project requirements, identifying potential issues, and providing solutions to resolve the issues.

Qualifications:

The ideal candidate will have a Ph.D. with 5+ years experience (or MS with 10+ years experience) in molecular biology, biochemistry, biotechnology or biological sciences 
This individual will be a highly motivated scientist with a proven track record in antibody engineering, preferably with post-doctoral experience in an academic or industry setting (for Ph.D. level candidate). 
A strong background in molecular biology, with extensive experience in antibody engineering, antibody expression and purification, and biochemical and biophysical methods for the analysis of antibodies is required. 
Familiarity with antibody biology, phage display technology, and affinity maturation, and interpretation of computational modeling of antibody-antigen interactions would be useful. Further, experience in preclinical development of therapeutic antibodies is desirable but not required. 
Strong communication skills, both oral and written, in Chinese and English. 
The incumbent will be required to focus on multiple issues at one time, and must have the ability to organize and direct diverse activities in a changing environment, often under time pressure. 
With a mature, self-confident and well-balanced personality, it is essential that the candidate also possess a high standard of ethical and intellectual integrity.

公司业务涵盖了抗体早期研发、小分子早期研发、药理药效、药代药动及早期毒理、生物药CMC、化药CMC、临床样品生产等新药研发各环节，为客户提供整合一体化的新药研发外包服务，已经服务过的国内外制药企业和生物医药技术公司1000余家，其中包括全球排名前20位的医药和生物技术企业。